Jun Qiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun Qiao has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Siim Pauklin
Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Headington, Oxford, UK
9 shared publications - Yuliang Feng
Department of Pharmacology, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, China
9 shared publications Kaixin Yao
Department of Nephrology, Shanxi Kidney Disease Institute, Second Hospital of Shanxi Medical University, Taiyuan, China
8 shared publicationsLiuyang Cai
Department of Pharmacology, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, China
8 shared publicationsYuhui Zhao
Department of Rheumatology, Shanxi Key Laboratory of Immunomicroecology, Second Hospital of Shanxi Medical University, Taiyuan, China
8 shared publicationsMinjing Chang
School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China
6 shared publications
Latest Publications
- 31 October 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
From 3D to 4D: spatiotemporal genome architecture and functional genomics in cardiovascular disease
The human genome is highly organized within the nucleus and is remodelled across physiological and disease states. Enabled by rapidly advancing technologies for mapping three-dimensional chromatin architecture, recent works have begun to define how three-dimensional chromatin architecture changes in the cardiovascular system and how these changes influence gene regulation. Here, we summarize the hierarchical folding features of 3D chromatin architecture and discuss major sequencing- and imaging-based strategies for mapping chromatin organization, including emerging single-cell and multimodal approaches that extend static 3D maps towards a spatiotemporal 4D nucleome perspective. We highlight how genetic variants, mechanical forces, metabolic-inflammatory stress, and lamina–genome disruption reshape chromatin topology in heart development, ageing, and cardiovascular diseases. Representative examples across cardiovascular diseases illustrate how altered enhancer–promoter communication, chromatin insulation, and nuclear positioning can contribute to pathogenic gene regulation. Finally, we discuss the therapeutic potential of 3D genome engineering and propose that the near-term translational value of cardiovascular 3D genomics lies primarily in improving disease–gene nomination and therapeutic target prioritization, while direct manipulation of chromatin architecture remains a promising but technically challenging frontier.
- 31 October 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
From 3D to 4D: spatiotemporal genome architecture and functional genomics in cardiovascular disease
The human genome is highly organized within the nucleus and is remodelled across physiological and disease states. Enabled by rapidly advancing technologies for mapping three-dimensional chromatin architecture, recent works have begun to define how three-dimensional chromatin architecture changes in the cardiovascular system and how these changes influence gene regulation. Here, we summarize the hierarchical folding features of 3D chromatin architecture and discuss major sequencing- and imaging-based strategies for mapping chromatin organization, including emerging single-cell and multimodal approaches that extend static 3D maps towards a spatiotemporal 4D nucleome perspective. We highlight how genetic variants, mechanical forces, metabolic-inflammatory stress, and lamina–genome disruption reshape chromatin topology in heart development, ageing, and cardiovascular diseases. Representative examples across cardiovascular diseases illustrate how altered enhancer–promoter communication, chromatin insulation, and nuclear positioning can contribute to pathogenic gene regulation. Finally, we discuss the therapeutic potential of 3D genome engineering and propose that the near-term translational value of cardiovascular 3D genomics lies primarily in improving disease–gene nomination and therapeutic target prioritization, while direct manipulation of chromatin architecture remains a promising but technically challenging frontier.
- Open Access
- 26 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (26) , e49425
Prevalence and control of asthma among US youths aged 12 to 19 years (2001–2023): A cross-sectional study
Childhood asthma is linked to socioeconomic factors, but prior studies and CDC reports lack 22-year stratified analyses of the 12 to 19 years subgroup, simultaneous assessment of multiple outcomes, and evaluation of post-2012 disparity changes. This age group is a critical transition period for asthma management, with long-term trends and disparities poorly understood. To systematically explore long-term trends in asthma prevalence and self-reported poor control indicators (asthma attacks, ED visits) among US youths aged 12 to 19 years, and sociodemographic disparities over 2001 to 2023. This cross-sectional trend analysis used data from the National Health and Nutrition Examination Survey spanning 22 years (2001–2023), including 17,096 adolescents (3290 with current asthma). Sociodemographic subgroups were defined by age and race/ethnicity. Analyses incorporated combined mobile examination center (MEC) and interview weights to account for National Health And Nutrition Examination Survey’ complex sampling design. A sensitivity analysis excluded the 2017 to 2020 cycle to address COVID-19-related data disruptions. Asthma prevalence remained disproportionately high in non-Hispanic Black youth, with no statistically significant narrowing of disparities post-2012 (2.17% in 2013–2016 vs 3.99% in 2021–2023; P > .05). Self-reported poor control indicators were suboptimal overall, with no detectable improvement trends during the study period. Sensitivity analysis (excluding 2017–2020) confirmed the robustness of core findings. Persistent sociodemographic disparities in adolescent asthma burden highlight the need for targeted interventions addressing structural inequities. Future studies should include confounder adjustment to clarify potential causal pathways.
- 26 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (26) , e49425
Open AccessPrevalence and control of asthma among US youths aged 12 to 19 years (2001–2023): A cross-sectional study
Childhood asthma is linked to socioeconomic factors, but prior studies and CDC reports lack 22-year stratified analyses of the 12 to 19 years subgroup, simultaneous assessment of multiple outcomes, and evaluation of post-2012 disparity changes. This age group is a critical transition period for asthma management, with long-term trends and disparities poorly understood. To systematically explore long-term trends in asthma prevalence and self-reported poor control indicators (asthma attacks, ED visits) among US youths aged 12 to 19 years, and sociodemographic disparities over 2001 to 2023. This cross-sectional trend analysis used data from the National Health and Nutrition Examination Survey spanning 22 years (2001–2023), including 17,096 adolescents (3290 with current asthma). Sociodemographic subgroups were defined by age and race/ethnicity. Analyses incorporated combined mobile examination center (MEC) and interview weights to account for National Health And Nutrition Examination Survey’ complex sampling design. A sensitivity analysis excluded the 2017 to 2020 cycle to address COVID-19-related data disruptions. Asthma prevalence remained disproportionately high in non-Hispanic Black youth, with no statistically significant narrowing of disparities post-2012 (2.17% in 2013–2016 vs 3.99% in 2021–2023; P > .05). Self-reported poor control indicators were suboptimal overall, with no detectable improvement trends during the study period. Sensitivity analysis (excluding 2017–2020) confirmed the robustness of core findings. Persistent sociodemographic disparities in adolescent asthma burden highlight the need for targeted interventions addressing structural inequities. Future studies should include confounder adjustment to clarify potential causal pathways.
- Open Access
- 17 April 2026
- Published by Wolters Kluwer Health in Current Urology
- Vol. 20 (4) , 253-256
Trends in urinary incontinence among women in the United States from 2001 to 2023
- 17 April 2026
- Published by Wolters Kluwer Health in Current Urology
- Vol. 20 (4) , 253-256
Open AccessTrends in urinary incontinence among women in the United States from 2001 to 2023
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in Vascular Investigation and Therapy
- Vol. 9 (2) , 76-81
Trends of venous thromboembolism mortality rate among US adults, 1999–2024
BACKGROUND: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism, is a major cause of cardiovascular morbidity and mortality in the United States. This study examined long-term trends in VTE-related mortality from 1999 to 2024, with a focus on demographic and geographic disparities. METHODS: We conducted a nationwide population-based study using mortality data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research database (1999–2024). Adults aged ≥ 25 years with VTE (ICD-10 codes I26, I80, and I82) listed as the underlying cause of death were included. Age-adjusted mortality rates (AAMRs) were calculated, and temporal trends were assessed using Joinpoint regression. Analyses were stratified by age, sex, race/ethnicity, and US Census region. RESULTS: A total of 283,805 VTE-related deaths were identified during the study period. The overall AAMR declined from 6.46 to 4.59 per 100,000 population, corresponding to an average annual percent change of − 1.43% (95% confidence interval: −2.35 to − 0.50). Despite this overall decline, important subgroup disparities persisted. Mortality increased among adults aged 25–44 years, whereas older adults consistently exhibited the highest absolute mortality rates. Non-Hispanic Black individuals and residents of the Southern United States also experienced persistently elevated mortality throughout the study period. CONCLUSION: Although VTE-related mortality in the United States declined between 1999 and 2024, substantial disparities persisted across age, race/ethnicity, and geographic regions. These findings underscore the need for targeted prevention strategies and equitable access to timely diagnosis and evidence-based VTE care.
- 1 April 2026
- Published by Wolters Kluwer Health in Vascular Investigation and Therapy
- Vol. 9 (2) , 76-81
Open AccessTrends of venous thromboembolism mortality rate among US adults, 1999–2024
BACKGROUND: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism, is a major cause of cardiovascular morbidity and mortality in the United States. This study examined long-term trends in VTE-related mortality from 1999 to 2024, with a focus on demographic and geographic disparities. METHODS: We conducted a nationwide population-based study using mortality data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research database (1999–2024). Adults aged ≥ 25 years with VTE (ICD-10 codes I26, I80, and I82) listed as the underlying cause of death were included. Age-adjusted mortality rates (AAMRs) were calculated, and temporal trends were assessed using Joinpoint regression. Analyses were stratified by age, sex, race/ethnicity, and US Census region. RESULTS: A total of 283,805 VTE-related deaths were identified during the study period. The overall AAMR declined from 6.46 to 4.59 per 100,000 population, corresponding to an average annual percent change of − 1.43% (95% confidence interval: −2.35 to − 0.50). Despite this overall decline, important subgroup disparities persisted. Mortality increased among adults aged 25–44 years, whereas older adults consistently exhibited the highest absolute mortality rates. Non-Hispanic Black individuals and residents of the Southern United States also experienced persistently elevated mortality throughout the study period. CONCLUSION: Although VTE-related mortality in the United States declined between 1999 and 2024, substantial disparities persisted across age, race/ethnicity, and geographic regions. These findings underscore the need for targeted prevention strategies and equitable access to timely diagnosis and evidence-based VTE care.
- Open Access
Heart-lung connections: Phenotypic and genetic insights from a large-scale genome-wide cross-trait analysis
Background: Extensive comorbidity between cardiovascular (CVD) and respiratory (RT) diseases is well-documented, yet the shared genetic mechanisms remain elusive. Genetic pleiotropy may play a pivotal role in understanding the intricate comorbidity patterns associated with cardiovascular and respiratory conditions. Methods: Our comprehensive analysis encompasses the largest available GWAS dataset of European ancestry covering six major CVDs (atrial fibrillation, coronary artery disease, venous thromboembolism, heart failure, peripheral arterial disease, and stroke) and four prevalent RTs (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and sleep apnea). Initially, we aimed to unveil the common genetic basis of major CVDs, through genome-wide and local genetic correlations and polygenic overlap. Subsequently, the shared genetic mechanisms between RTs and CVDs was investigated in terms of both horizontal and vertical pleiotropy. From a horizontal pleiotropy perspective, cross-trait analysis was utilized to identify pleiotropic genetic determinants including genomic loci, single nucleotide polymorphisms (SNPs), genes, biological pathways, and protein targets. From a vertical pleiotropic perspective, Mendelian randomization was employed to evaluate potential causal relationships between CVDs and RTs. Results: Our study confirmed the significant existence of genetic correlations and overlaps between CVDs and RTs. Pleiotropy analysis under the composite null hypothesis identified 17,964 significant potential pleiotropic SNPs in 24 trait pairs, with 73 pleiotropic loci and 69 colocalized loci detected. Gene-based analysis revealed 59 candidate pleiotropic genes, highly enriched in unsaturated fatty acid biosynthetic processes and MHC class I-mediated antigen processing and presentation. Mendelian randomization analysis demonstrated a positive causal relationship only between chronic obstructive pulmonary disease and heart failure. Overall, the genetic basis between CVDs and RTs was inconsistent with vertical pleiotropy, suggesting the dramatic impact of horizontal pleiotropy. Conclusions: Our findings indicate widely distributed pleiotropic genetic determinants between RTs and CVDs across the genome. These results support a common genetic basis for RTs and CVDs and are important for intervention and therapeutic targets in comorbidities. Clinical Perspective: What Is New?: A common genetic underpinning for CVDs and RTs has been identified using a variety of approaches and further explained as a shared genetic mechanism mediated by pleiotropy. The systematic atlas of horizontal pleiotropy addressed key questions about pleiotropic SNPs, genomic loci, genes, functional features, and protein targets contributing to comorbidity between CVDs and RTs. The systematic atlas of vertical pleiotropy highlighted causal associations between CVDs and RTs beyond the observed correlations. What Are the Clinical Implications?: This study may help to elucidate the shared genetic mechanism between respiratory and cardiovascular diseases and further prioritize shared drug targets between RTs and CVDs.
Open AccessHeart-lung connections: Phenotypic and genetic insights from a large-scale genome-wide cross-trait analysis
Background: Extensive comorbidity between cardiovascular (CVD) and respiratory (RT) diseases is well-documented, yet the shared genetic mechanisms remain elusive. Genetic pleiotropy may play a pivotal role in understanding the intricate comorbidity patterns associated with cardiovascular and respiratory conditions. Methods: Our comprehensive analysis encompasses the largest available GWAS dataset of European ancestry covering six major CVDs (atrial fibrillation, coronary artery disease, venous thromboembolism, heart failure, peripheral arterial disease, and stroke) and four prevalent RTs (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and sleep apnea). Initially, we aimed to unveil the common genetic basis of major CVDs, through genome-wide and local genetic correlations and polygenic overlap. Subsequently, the shared genetic mechanisms between RTs and CVDs was investigated in terms of both horizontal and vertical pleiotropy. From a horizontal pleiotropy perspective, cross-trait analysis was utilized to identify pleiotropic genetic determinants including genomic loci, single nucleotide polymorphisms (SNPs), genes, biological pathways, and protein targets. From a vertical pleiotropic perspective, Mendelian randomization was employed to evaluate potential causal relationships between CVDs and RTs. Results: Our study confirmed the significant existence of genetic correlations and overlaps between CVDs and RTs. Pleiotropy analysis under the composite null hypothesis identified 17,964 significant potential pleiotropic SNPs in 24 trait pairs, with 73 pleiotropic loci and 69 colocalized loci detected. Gene-based analysis revealed 59 candidate pleiotropic genes, highly enriched in unsaturated fatty acid biosynthetic processes and MHC class I-mediated antigen processing and presentation. Mendelian randomization analysis demonstrated a positive causal relationship only between chronic obstructive pulmonary disease and heart failure. Overall, the genetic basis between CVDs and RTs was inconsistent with vertical pleiotropy, suggesting the dramatic impact of horizontal pleiotropy. Conclusions: Our findings indicate widely distributed pleiotropic genetic determinants between RTs and CVDs across the genome. These results support a common genetic basis for RTs and CVDs and are important for intervention and therapeutic targets in comorbidities. Clinical Perspective: What Is New?: A common genetic underpinning for CVDs and RTs has been identified using a variety of approaches and further explained as a shared genetic mechanism mediated by pleiotropy. The systematic atlas of horizontal pleiotropy addressed key questions about pleiotropic SNPs, genomic loci, genes, functional features, and protein targets contributing to comorbidity between CVDs and RTs. The systematic atlas of vertical pleiotropy highlighted causal associations between CVDs and RTs beyond the observed correlations. What Are the Clinical Implications?: This study may help to elucidate the shared genetic mechanism between respiratory and cardiovascular diseases and further prioritize shared drug targets between RTs and CVDs.
- Open Access
- 29 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1)
Global, Regional, and National Prevalence for Type 2 Diabetes Among Women of Childbearing Age, 1992–2021: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021
In 2021, global T2DM prevalence among WCBAs reached 73.86 million (95% UI: 63.43–85.32 million), with China, India, and the United States leading. Greenland exhibited the largest rise in age‐standardized prevalence (7.93%), with an annual increase of 11.32% (95% UI: 8.33%–14.39%). From 1992 to 2021, prevalence rose in 195 countries, declined in eight, and remained stable in one. Prevalence increased with age, peaking in women aged 45–49, and was higher in low‐SDI regions, which also experienced sharper increases. Period and cohort effects worsened globally, particularly in low‐SDI regions. Population growth drove burden increases in low‐SDI areas, while epidemiological factors dominated in high‐SDI regions. T2DM‐related visual impairment was more severe in low‐ and medium‐SDI regions. Projections for 2022–2030 predict unfavorable increasing trends. T2DM prevalence among WCBAs has steadily risen since 1992, with worsening inequalities and healthcare disparities. Projections to 2030 underscore the need for targeted prevention and treatment strategies, particularly in low‐ and medium‐SDI regions.
- 29 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1)
Open AccessGlobal, Regional, and National Prevalence for Type 2 Diabetes Among Women of Childbearing Age, 1992–2021: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021
In 2021, global T2DM prevalence among WCBAs reached 73.86 million (95% UI: 63.43–85.32 million), with China, India, and the United States leading. Greenland exhibited the largest rise in age‐standardized prevalence (7.93%), with an annual increase of 11.32% (95% UI: 8.33%–14.39%). From 1992 to 2021, prevalence rose in 195 countries, declined in eight, and remained stable in one. Prevalence increased with age, peaking in women aged 45–49, and was higher in low‐SDI regions, which also experienced sharper increases. Period and cohort effects worsened globally, particularly in low‐SDI regions. Population growth drove burden increases in low‐SDI areas, while epidemiological factors dominated in high‐SDI regions. T2DM‐related visual impairment was more severe in low‐ and medium‐SDI regions. Projections for 2022–2030 predict unfavorable increasing trends. T2DM prevalence among WCBAs has steadily risen since 1992, with worsening inequalities and healthcare disparities. Projections to 2030 underscore the need for targeted prevention and treatment strategies, particularly in low‐ and medium‐SDI regions.
- Open Access
Evolutionary divergence and expression of differential HLA alleles between donor and recipient influence acute GVHD onset after allogenetic HSCT
Acute graft-versus-host disease (aGVHD) remains a major complication after hematopoietic stem cell transplantation (HSCT), especially given haploidentical HSCT is now China’s primary method, yet this context lacks reliable predictors. aGVHD initiation, involving donor T cell activation by recipient conventional dendritic cells (cDCs), depends on donor-recipient HLA disparity and its expression. We therefore developed the donor and recipient-specific HLA evolutionary divergence (DRs_HED) algorithm to quantify relevant HLA differences, then integrated HLA expression in cDC to evaluate the combined predictive value. While DRs_HED correlated with aGVHD occurrence, links to organ severity varied: consistent for skin but not gastrointestinal aGVHD. Only cDCs expression of HLA-DRB1 correlated with presentation of associated minor histocompatibility antigens (miHAs). Integrating expression with DRs_HED improved prediction, raising the model’s AUC by about ∼10% to 0.607 ± 0.012 versus DRs_HED alone. Our findings show precise quantification of HLA disparity and expression improves aGVHD risk prediction, aiding future multi-factorial models.
Open AccessEvolutionary divergence and expression of differential HLA alleles between donor and recipient influence acute GVHD onset after allogenetic HSCT
Acute graft-versus-host disease (aGVHD) remains a major complication after hematopoietic stem cell transplantation (HSCT), especially given haploidentical HSCT is now China’s primary method, yet this context lacks reliable predictors. aGVHD initiation, involving donor T cell activation by recipient conventional dendritic cells (cDCs), depends on donor-recipient HLA disparity and its expression. We therefore developed the donor and recipient-specific HLA evolutionary divergence (DRs_HED) algorithm to quantify relevant HLA differences, then integrated HLA expression in cDC to evaluate the combined predictive value. While DRs_HED correlated with aGVHD occurrence, links to organ severity varied: consistent for skin but not gastrointestinal aGVHD. Only cDCs expression of HLA-DRB1 correlated with presentation of associated minor histocompatibility antigens (miHAs). Integrating expression with DRs_HED improved prediction, raising the model’s AUC by about ∼10% to 0.607 ± 0.012 versus DRs_HED alone. Our findings show precise quantification of HLA disparity and expression improves aGVHD risk prediction, aiding future multi-factorial models.
- Open Access
- 30 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Contribution of leukocyte telomere length to cardiovascular disease onset from genome-wide cross-trait analysis
Telomere shortening is a well-established marker of cellular aging and genomic instability. While the relationship between leukocyte telomere length and cardiovascular diseases has long been of interest, their genetic interplay remains incompletely understood. In this study, we observe substantial genetic overlap beyond genome-wide correlations and identify a potential causal relationship between leukocyte telomere length and coronary artery disease. Specifically, we discover 248 pleiotropic loci, 22 of which show strong evidence of colocalization. Some shared loci implicate multiple pleiotropic genes across different trait pairs, including ALDH2, ACAD10, TMEM116, SH2B3 (all at 12q24.12), TMED6 (16q22.1), SERPINF1 (17p13.3), and XPO7 (8p21.3). Functional analysis highlights key pathways involved in DNA biosynthesis and telomere maintenance. Notably, SH2B3 is validated through proteome-wide Mendelian randomization analysis, suggesting its potential as a therapeutic target. Here we report the shared genetic basis between leukocyte telomere length and cardiovascular diseases, providing valuable insights into future therapeutic developments.
- 30 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Open AccessContribution of leukocyte telomere length to cardiovascular disease onset from genome-wide cross-trait analysis
Telomere shortening is a well-established marker of cellular aging and genomic instability. While the relationship between leukocyte telomere length and cardiovascular diseases has long been of interest, their genetic interplay remains incompletely understood. In this study, we observe substantial genetic overlap beyond genome-wide correlations and identify a potential causal relationship between leukocyte telomere length and coronary artery disease. Specifically, we discover 248 pleiotropic loci, 22 of which show strong evidence of colocalization. Some shared loci implicate multiple pleiotropic genes across different trait pairs, including ALDH2, ACAD10, TMEM116, SH2B3 (all at 12q24.12), TMED6 (16q22.1), SERPINF1 (17p13.3), and XPO7 (8p21.3). Functional analysis highlights key pathways involved in DNA biosynthesis and telomere maintenance. Notably, SH2B3 is validated through proteome-wide Mendelian randomization analysis, suggesting its potential as a therapeutic target. Here we report the shared genetic basis between leukocyte telomere length and cardiovascular diseases, providing valuable insights into future therapeutic developments.
- Open Access
- 24 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Shared genetic architecture contributes to risk of major cardiovascular diseases
The extensive co-occurrence of cardiovascular diseases (CVDs), as evidenced by epidemiological studies, is supported by positive genetic correlations identified in comprehensive genetic investigations, suggesting a shared genetic basis. However, the precise genetic mechanisms underlying these associations remain elusive. By assessing genetic correlations, genetic overlap, and causal connections, we aim to shed light on common genetic underpinnings among major CVDs. Employing multi-trait analysis, we pursue diverse strategies to unveil shared genetic elements, encompassing SNPs, genes, gene sets, and functional categories with pleiotropic implications. Our study systematically quantifies genetic overlap beyond genome-wide genetic correlations across CVDs, while identifying a putative causal relationship between coronary artery disease (CAD) and heart failure (HF). We then pinpointed 38 genomic loci with pleiotropic influence across CVDs, of which the most influential pleiotropic locus is located at the LPA gene. Notably, 12 loci present high evidence of multi-trait colocalization and display congruent directional effects. Examination of genes and gene sets linked to these loci unveiled robust associations with circulatory system development processes. Intriguingly, distinct patterns predominantly driven by atrial fibrillation, coronary artery disease, and venous thromboembolism underscore the significant disparities between clinically defined CVD classifications and underlying shared biological mechanisms, according to functional annotation findings.
- 24 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessShared genetic architecture contributes to risk of major cardiovascular diseases
The extensive co-occurrence of cardiovascular diseases (CVDs), as evidenced by epidemiological studies, is supported by positive genetic correlations identified in comprehensive genetic investigations, suggesting a shared genetic basis. However, the precise genetic mechanisms underlying these associations remain elusive. By assessing genetic correlations, genetic overlap, and causal connections, we aim to shed light on common genetic underpinnings among major CVDs. Employing multi-trait analysis, we pursue diverse strategies to unveil shared genetic elements, encompassing SNPs, genes, gene sets, and functional categories with pleiotropic implications. Our study systematically quantifies genetic overlap beyond genome-wide genetic correlations across CVDs, while identifying a putative causal relationship between coronary artery disease (CAD) and heart failure (HF). We then pinpointed 38 genomic loci with pleiotropic influence across CVDs, of which the most influential pleiotropic locus is located at the LPA gene. Notably, 12 loci present high evidence of multi-trait colocalization and display congruent directional effects. Examination of genes and gene sets linked to these loci unveiled robust associations with circulatory system development processes. Intriguingly, distinct patterns predominantly driven by atrial fibrillation, coronary artery disease, and venous thromboembolism underscore the significant disparities between clinically defined CVD classifications and underlying shared biological mechanisms, according to functional annotation findings.
- Open Access
Dissecting the pleiotropic genetic architecture linking telomere biology to chronic respiratory diseases and lung function
Background: Leukocyte telomere length (LTL) has been implicated in aging and age-related diseases, including chronic respiratory diseases (CRDs). However, the extent and mechanisms of shared genetic architecture between LTL and respiratory health indicators (such as CRDs and lung function parameters) remain incompletely understood. Methods: We first systematically characterized the genetic correlations and genetic overlaps between LTL and multiple respiratory health indicators. We then performed horizontal pleiotropy analysis by integrating SNP-level functional annotation, gene mapping, and pathway analysis to identify candidate pleiotropic loci, genes, and shared biological pathways. Finally, we assessed the causal relationships among these trait pairs using the latent causal variable (LCV) and MRlap. Results: There was extensive genetic overlap between LTL and respiratory health indicators, regardless of whether these trait pairs had significant genetic associations. We identified 27,885 candidate pleiotropic loci and 82 pleiotropic genes. Notably, five key genes, such as STN1 , MPHOSPH9 , MTRFR , MAX , and UCKL1 , showed significant pleiotropic effects in multiple phenotype pairs and mediated different patterns of genetic associations. Pathway enrichment analysis of these pleiotropic genes highlighted the close association of specific trait pairs with RNA metabolism and telomere maintenance. Finally, vertical pleiotropy analysis revealed negative causal associations of LTL-idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease-LTL. Conclusions: Our findings reinforce the roles of telomere biology and RNA processing in the pathogenesis of chronic lung diseases and support a shared genetic basis for common molecular pathways. Graphical Analysis flow chart of LTL and seven respiratory health indicators: We used large-scale genome-wide association study (GWAS) summary statistics from individuals of European ancestry to conduct a comprehensive pleiotropy analysis of leukocyte telomere length (LTL) and seven respiratory health indicators. First, we systematically assessed genome-wide genetic correlation, global and local genetic overlap, and local genetic correlation across these phenotype pairs, revealing a shared genetic architecture. Recognizing that such associations may arise from vertical or horizontal pleiotropy, we next focused on capturing horizontal pleiotropy. Using multiple complementary statistical genetics methods, we integrated multidimensional evidence—spanning shared single-nucleotide polymorphisms (SNPs), genes, and molecular pathways—to characterize the genetic interconnections between LTL and respiratory traits. Finally, we performed causal inference analyses to evaluate the role of vertical pleiotropy, estimating the directional effects of LTL on respiratory health indicators. Together, this multi-layered pleiotropy analysis delineates a shared genetic landscape between LTL and respiratory health, offering novel insights into the mechanisms of lung aging and disease progression. LTL, leukocyte telomere length; COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; OSA, sleep apnoea; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity. take home: The first study to comprehensively explore the common genetic architecture between LTL and respiratory health indicators (CRDs and LF parameters) 12q24.31 ( MPHOSPH9 , MTRFR ), 14q23.3 ( MAX ), 20q13.33 ( UCKL1 ) and 10q24.33 ( STN1 ) are key pleiotropic loci and genes between LTL and respiratory health indicators Genetically predicted LTL is causally associated with increased risk of IPF
Open AccessDissecting the pleiotropic genetic architecture linking telomere biology to chronic respiratory diseases and lung function
Background: Leukocyte telomere length (LTL) has been implicated in aging and age-related diseases, including chronic respiratory diseases (CRDs). However, the extent and mechanisms of shared genetic architecture between LTL and respiratory health indicators (such as CRDs and lung function parameters) remain incompletely understood. Methods: We first systematically characterized the genetic correlations and genetic overlaps between LTL and multiple respiratory health indicators. We then performed horizontal pleiotropy analysis by integrating SNP-level functional annotation, gene mapping, and pathway analysis to identify candidate pleiotropic loci, genes, and shared biological pathways. Finally, we assessed the causal relationships among these trait pairs using the latent causal variable (LCV) and MRlap. Results: There was extensive genetic overlap between LTL and respiratory health indicators, regardless of whether these trait pairs had significant genetic associations. We identified 27,885 candidate pleiotropic loci and 82 pleiotropic genes. Notably, five key genes, such as STN1 , MPHOSPH9 , MTRFR , MAX , and UCKL1 , showed significant pleiotropic effects in multiple phenotype pairs and mediated different patterns of genetic associations. Pathway enrichment analysis of these pleiotropic genes highlighted the close association of specific trait pairs with RNA metabolism and telomere maintenance. Finally, vertical pleiotropy analysis revealed negative causal associations of LTL-idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease-LTL. Conclusions: Our findings reinforce the roles of telomere biology and RNA processing in the pathogenesis of chronic lung diseases and support a shared genetic basis for common molecular pathways. Graphical Analysis flow chart of LTL and seven respiratory health indicators: We used large-scale genome-wide association study (GWAS) summary statistics from individuals of European ancestry to conduct a comprehensive pleiotropy analysis of leukocyte telomere length (LTL) and seven respiratory health indicators. First, we systematically assessed genome-wide genetic correlation, global and local genetic overlap, and local genetic correlation across these phenotype pairs, revealing a shared genetic architecture. Recognizing that such associations may arise from vertical or horizontal pleiotropy, we next focused on capturing horizontal pleiotropy. Using multiple complementary statistical genetics methods, we integrated multidimensional evidence—spanning shared single-nucleotide polymorphisms (SNPs), genes, and molecular pathways—to characterize the genetic interconnections between LTL and respiratory traits. Finally, we performed causal inference analyses to evaluate the role of vertical pleiotropy, estimating the directional effects of LTL on respiratory health indicators. Together, this multi-layered pleiotropy analysis delineates a shared genetic landscape between LTL and respiratory health, offering novel insights into the mechanisms of lung aging and disease progression. LTL, leukocyte telomere length; COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; OSA, sleep apnoea; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity. take home: The first study to comprehensively explore the common genetic architecture between LTL and respiratory health indicators (CRDs and LF parameters) 12q24.31 ( MPHOSPH9 , MTRFR ), 14q23.3 ( MAX ), 20q13.33 ( UCKL1 ) and 10q24.33 ( STN1 ) are key pleiotropic loci and genes between LTL and respiratory health indicators Genetically predicted LTL is causally associated with increased risk of IPF